tiprankstipranks
Trending News
More News >
Strides Pharma Science Ltd (IN:STAR)
:STAR
India Market

Strides Pharma Science Ltd (STAR) Financial Statements

Compare
3 Followers

Strides Pharma Science Ltd Financial Overview

Strides Pharma Science Ltd's market cap is currently ₹85.66B. The company's EPS TTM is ₹14.4; its P/E ratio is 21.51; and it has a dividend yield of 0.41%. Strides Pharma Science Ltd is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 46.24B₹ 38.28B₹ 36.68B₹ 30.70B₹ 32.80B
Gross Profit₹ 26.44B₹ 8.51B₹ 8.05B₹ 14.57B₹ 9.59B
Operating Income₹ 17.81B₹ 3.02B₹ 1.24B₹ -2.52B₹ 3.15B
EBITDA₹ 8.62B₹ 4.39B₹ 5.03B₹ -1.35B₹ 7.25B
Net Income₹ 35.93B₹ -706.14M₹ -2.21B₹ -4.60B₹ 2.68B
Balance Sheet
Cash & Short-Term Investments₹ 2.06B₹ 2.90B₹ 3.61B₹ 1.84B₹ 2.75B
Total Assets₹ 60.49B₹ 58.40B₹ 66.38B₹ 69.76B₹ 70.15B
Total Debt₹ 18.80B₹ 25.17B₹ 30.30B₹ 30.25B₹ 23.48B
Net Debt₹ 17.43B₹ 23.56B₹ 27.26B₹ 28.54B₹ 22.22B
Total Liabilities₹ 34.62B₹ 37.68B₹ 44.66B₹ 45.93B₹ 42.01B
Stockholders' Equity₹ 25.52B₹ 21.26B₹ 22.12B₹ 23.59B₹ 27.77B
Cash Flow
Free Cash Flow₹ 4.42B₹ 5.83B₹ -505.27M₹ -4.01B₹ 1.84B
Operating Cash Flow₹ 6.84B₹ 7.01B₹ 444.11M₹ -2.58B₹ 4.81B
Investing Cash Flow₹ -896.89M₹ -1.50B₹ 3.02B₹ -1.19B₹ -5.21B
Financing Cash Flow₹ -6.43B₹ -6.93B₹ -2.14B₹ 4.21B₹ -157.96M
Currency in INR

Strides Pharma Science Ltd Earnings and Revenue History

Strides Pharma Science Ltd Debt to Assets

Strides Pharma Science Ltd Cash Flow

Strides Pharma Science Ltd Forecast EPS vs Actual EPS